Loading…
Ray DalioAdded
Bridgewater Associates · Q2 2026
$3.37M
324.08K shares · 0.0% of portfolio
PERRIGO Co plc
PERRIGO Co plc (PRGO) is listed on NYSE and classified in Drug Manufacturers - Specialty & Generic, part of the Healthcare sector. It is headquartered in Dublin, Ireland and has 8,100 employees. The company is worth $2.27B. Revenue was $4.25B in fiscal 2025, down 2.8% from the year before. It reported a net loss of $1.43B. The share price is 25.6% below its 52-week high of $22.01. It pays a dividend yielding 7.09%, and has raised its annual dividend for 21 years in a row in our records. 7 of the 38 superinvestors we track held it at the end of Q2 2026. The largest position belongs to Cliff Asness (AQR Capital Management), at $35.26M. In that quarter, 4 of them opened or added to the position and 2 reduced it. No open-market insider trades in it were filed over the last 30 days.
Written from the data on this page: SEC filings (13F, Form 4, annual reports) and market prices.
Year by year, from the annual reports; dividends from the payments themselves.
Bars are year-end balances; lines are what happened during the year.
Major managers that reported this stock in their latest 13F.
▼ -54.7% over 5Y.
today you would have $453.93▼ -54.6%
Dividends reinvested, splits accounted for. Past prices say what happened, not what will.
The last 14 closed years, each at that year’s closing price and reported numbers.
| Indicator | Median | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Year-end price | $13.92 | $25.71 | $32.18 | $34.09 | $38.90 | $44.72 | $51.66 | $38.75 | $87.16 | $83.23 | $144.70 | $167.16 | $153.46 | $104.03 | |
| P/E | 48.3x | — | — | — | — | — |
Seven formulas applied to the reported numbers, each with its assumption next to the result. None of them predicts a price.
This formula has no meaning here — usually a loss, negative cash flow, or a missing input.
This formula has no meaning here — usually a loss, negative cash flow, or a missing input.
This formula has no meaning here — usually a loss, negative cash flow, or a missing input.
This formula has no meaning here — usually a loss, negative cash flow, or a missing input.
This formula has no meaning here — usually a loss, negative cash flow, or a missing input.
This formula has no meaning here — usually a loss, negative cash flow, or a missing input.
Companies of similar size in Healthcare, for comparison. The columns are the same ones above, in the same order.
| Stock | Price | P/E | P/B | Dividend yield | ROE | Market cap |
|---|---|---|---|---|---|---|
| FTREFortrea Holdings Inc. | $23.92 | — | 4.3x | 0.00% | -15.30% | $2.27B |
| CLDXCelldex Therapeutics, Inc. | $28.97 | — | 3.2x | 0.00% | -43.88% | $2.28B |
| PGENPrecigen Inc | $6.39 | — | 52.4x | 0.00% | -837.08% | $2.29B |
| ADUSAddus HomeCare Corp | $122.67 |
| — |
| 48.3x |
| 40.8x |
| 103.8x |
| — |
| 149.2x |
| 83.2x |
| 32.8x |
| 24.4x |
| P/S | 1.6x | 0.5x | 0.8x | 0.9x | 1.0x | 1.3x | 1.5x | 1.8x | 1.1x | 2.5x | 2.3x | 5.0x | 5.5x | 4.1x | 3.1x |
| P/B | 1.1x | 0.7x | 0.8x | 0.9x | 0.9x | 1.0x | 1.1x | 1.2x | 0.9x | 2.0x | 2.0x | 2.0x | 2.6x | 6.2x | 5.3x |
| EPS | -$10.29 | -$1.25 | -$0.09 | -$1.04 | -$0.52 | -$1.19 | $1.07 | $0.95 | $0.84 | -$28.01 | $0.97 | $2.01 | $4.68 | $4.27 |
| Dividend yield | 1.77% | 6.25% | 4.29% | 3.39% | 3.05% | 2.47% | 2.01% | 1.59% | 1.96% | 0.73% | 0.70% | 0.35% | 0.25% | 0.24% | 0.32% |
| Payout | 51.55% | — | — | — | — | — | — | 76.64% | 80.00% | 76.19% | — | 51.55% | 20.90% | 7.91% | 7.73% |
| Profit margin | 1.07% | -33.51% | -3.93% | -0.27% | -3.16% | -1.66% | -3.98% | 3.78% | 2.77% | 2.42% | -75.99% | 3.22% | 5.73% | 12.48% | 12.66% |
| ROE | 0.50% | -48.56% | -3.98% | -0.27% | -2.90% | -1.34% | -2.88% | 2.52% | 2.31% | 1.94% | -67.35% | 1.27% | 2.67% | 18.95% | 21.70% |
Median of the years shown; P/E years above 200x are left out.
Dividend growing 5.9% a year against a 7.4% required return, from the stock’s beta.
The average of the method families that answered, not of the seven numbers: four of the seven start from the same earnings per share.
1 methods answered, across 1 families.
Room for errors in the reported numbers.
+275.4% from the average.
Models, not forecasts, and not investment advice. How each formula works →
| 20.7x |
| 2.0x |
| 0.00% |
| 9.71% |
| $2.29B |
| PGNYProgyny, Inc. | $29.12 | 31.7x | 4.9x | 0.00% | 16.24% | $2.23B |
| UFPTUfp Technologies Inc | $297.33 | 31.3x | 5.0x | 0.00% | 17.05% | $2.3B |
